Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,880,924
+$27,845,365 QoQ
Shares Held
39,086
+88.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
6.28%
of 13F equity value
Holder Rank
#572
of 4,622 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Defilade Capital Management, L.P. holds $89,544,495 across 2 Drug Manufacturers - General names. LLY ranks #1 (52.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
39,086 | $46,880,924 | |
| 2 | PFE |
Pfizer Inc
|
1,771,743 | $42,663,571 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,880,924 | 39,086 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,035,559 | 20,696 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $34,336,029 | 31,950 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||